Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05256225
- Conditions
- Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
NCT05112601
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University Cancer and Blood Center LLC Athens, Georgia, United States
- Augusta University Medical Center Augusta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
NCT07436793
- Conditions
- Endometrial Endometrioid Adenocarcinoma, Endometrial Hyperplasia, Female Urogenital Diseases, +5 more
- Locations
-
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- University of New Mexico Cancer Center Albuquerque, New Mexico, United States
- University of Utah Sugarhouse Health Center Salt Lake City, Utah, United States
- University of Virginia Cancer Center Charlottesville, Virginia, United States
NCT05542407
- Conditions
- Body Weight, Carcinosarcoma, Clear Cell Endometrial Carcinoma, +33 more
- Locations
-
- Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
Recruiting
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
NCT03422198
- Conditions
- Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, +6 more
- Locations
-
- Stanford Cancer Center Palo Alto, California, United States
- Loyola University Medical Center Maywood, Illinois, United States
- MD Anderson Houston, Texas, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
NCT04049227
- Conditions
- Endometrial Endometrioid Adenocarcinoma
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT02020707
- Conditions
- Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma, +45 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02728258
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
- Northside Hospital Atlanta, Georgia, United States
NCT00478426
- Conditions
- Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, +5 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Active, Not Recruiting
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
NCT03914612
- Conditions
- Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +30 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
Active, Not Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer
NCT04214067
- Conditions
- Carcinosarcoma, Endometrial Endometrioid Adenocarcinoma, Neoplasms, +6 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Community Cancer Institute Clovis, California, United States
- University Oncology Associates Clovis, California, United States
- John Muir Medical Center-Concord Concord, California, United States